Owlet (OWLT) Revenue Growth (1y) (2021 - 2026)
Owlet (OWLT) Revenue Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 16.70% |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | 7.41% |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | 15.05% |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 6.08% |
| 10 | Owlet | 146.68 Mn | 105.67 Mn | 12.24 Mn | 6.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.41% |
| Dec 31, 2025 | 29.62% |
| Sep 30, 2025 | 44.60% |
| Jun 30, 2025 | 25.91% |
| Mar 31, 2025 | 43.08% |
| Dec 31, 2024 | -2.47% |
| Sep 30, 2024 | 140.93% |
| Jun 30, 2024 | 58.15% |
| Mar 31, 2024 | 37.39% |
| Dec 31, 2023 | 75.68% |
| Sep 30, 2023 | -47.11% |
| Jun 30, 2023 | -28.67% |
| Mar 31, 2023 | -50.15% |
| Dec 31, 2022 | 575.96% |
| Sep 30, 2022 | -44.90% |
| Jun 30, 2022 | -26.43% |
| Mar 31, 2022 | -1.70% |
| Dec 31, 2021 | -111.96% |
| Sep 30, 2021 | 48.83% |